Melissa Mathias
Memorial Sloan Kettering Cancer Center(US)Regeneron (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Lung Cancer Treatments and Mutations, Nonmelanoma Skin Cancer Studies
Most-Cited Works
- → PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma(2018)1,358 cited
- → Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma(2022)292 cited
- → Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors(2008)232 cited
- → Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing(2020)172 cited
- → Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice(2010)164 cited
- → Mature B cells class switched to IgD are autoreactive in healthy individuals(2007)137 cited